BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Islam R, Vance J, Poirier M, Zimmer J, Khadang A, Williams D, Zemo J, Lester T, Fjording M, Hays A, Hughes N, Garofolo F, Sheldon C, Guilbaud R, Satterwhite C, Colletti K, Groeber E, Renfrew H, Yu M, Lin J, Fang X, Wissel M, Beadnell T, Lin J, Shah S, Garofolo W, Savoie N, Hayes R, Pirro J, Kane C, Luna M, Xu A, Cape S, O'Dell M, Wheller R, Ritzen H, Farley E, Kierstead L, Mylott W, Tabler E, Yuan M, Karnik S, Voelker T, DuBey I, Williard C, Dong K, Shi J, Yamashita J. Recommendations on ELISpot assay validation by the GCC. Bioanalysis 2022;14:187-93. [PMID: 35135309 DOI: 10.4155/bio-2022-0010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Lyagoskin IV, Kargopolova PE, Obyedkov DA, Egorova IY, Shukurov RR. Intra-laboratory validated “TigraTest® SARS-CoV-2” — test assessing release of interferon gamma in vitro to identify peripheral blood T-lymphocytes specifically responding against SARS-CoV-2 virus antigens. Russian Journal of Infection and Immunity 2022;12:701-713. [DOI: 10.15789/2220-7619-ilv-1855] [Reference Citation Analysis]
2 Waerlop G, Leroux-roels G, Lambe T, Bellamy D, Medaglini D, Pettini E, Cox RJ, Trieu M, Davies R, Bredholt G, Montomoli E, Gianchecchi E, Clement F. Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium. Front Immunol 2022;13:984642. [DOI: 10.3389/fimmu.2022.984642] [Reference Citation Analysis]